Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apyx Medical (APYX) Other financing activities (2016 - 2025)

Apyx Medical's Other financing activities history spans 11 years, with the latest figure at $30000.0 for Q2 2025.

  • For Q2 2025, Other financing activities changed N/A year-over-year to $30000.0; the TTM value through Dec 2025 reached $60000.0, up 445.45%, while the annual FY2025 figure was $60000.0, 445.45% up from the prior year.
  • Other financing activities reached $30000.0 in Q2 2025 per APYX's latest filing, roughly flat from $30000.0 in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $1.8 million in Q1 2023 to a low of -$1.6 million in Q3 2023.
  • Average Other financing activities over 3 years is $43600.0, with a median of $30000.0 recorded in 2025.